INSTRUCTION

Oncology is rapidly gaining acceptance as a medical discipline throughout Asia. However, there is a need to increase awareness that the research, epidemiology, clinical spectrum and, of necessity, management strategies for cancer in this region are different from those in Western countries. It was therefore necessary that we, as scientists dedicated to the research and clinical activity of cancer, should join together to establish the Asian Oncology Society (AOS).

AOS has served as a unified organization of APFOCC(the Asian and Pacific Federation of Organizations for Cancer Research and Control) and ACOS(Asian Clinical Oncology Society) since 2018. APFOCC was founded on the purpose of cancer prevention and cancer control policies by Dr. Kunio Ohta and others (Tokyo Univ., Japan) in 1972 and ACOS was for clinical activities by Dr. Tetsuo Taguchi (Japan), the late Jin-Pok Kim (Korea) etc. in 1991. AOS will include every part of oncology as their mission ranging from basic, clinical research to cancer prevention, treatment, and education.

ARTICLE 1

The Society shall be known as the Asian Oncology Society (hereinafter known as AOS). The Society was established in 2019. The inaugural meeting was held on October, 2019 in Japan and was initiated by representatives from participating Oncology Societies in Asian countries.

ARTICLE 2

The objectives of the Society shall be:
• To bring together, on a common platform, scientists from Asian countries for a free exchange of ideas on the problems, challenges and methods of cancer management in the region.
• To mutually encourage, strengthen and improve facilities for cancer research, diagnosis and management in countries in the region where such help is needed.
• To seek the support of Government, non-Government and private agencies in achieving the improvement of cancer care throughout the Asian region.
• To encourage transfer of technology between countries in the region with the objective of improving overall standards of cancer research, diagnosis and management.
• To encourage membership of the Society throughout the region in order to promote and support the activities of members where such assistance is needed.
• To foster improvement of academic and scientific standards in oncology in the Asian region by encouraging research in the fields of oncology.

ARTICLE 3

China Anti-Cancer Association (CACA), China Society of Clinical Oncology (CSCO), Hong Kong Cancer Therapy Society, Academia of Head and Neck Oncology of Karnataka (AHNOK), Association of Maharashtra Medical Oncologists (AMMO), Gujarat OncoLions Society (GOL), Indian Association of Surgical Oncology (IASO), Indian Cooperative Oncology Network, Indian Society of Medical & Pediatric Oncology (ISMPO), Indian Society of Oncology, Integrated Academic Society of Clinical Oncology (IASCO), Leadership Immuno Oncology Network, Molecular Oncology Society, Saarc Federation of Oncology, Tamil Nadu Medical & Pediatric Oncology Society (TAMPOS), Indonesian Association for the Study of The Liver(Ina ASL), Indonesian Radiation Oncology Society, Indonesian Society of Gynecologic Oncology(INASGO), Indonesian Urology Oncology Society (IUOS), The Indonesian Society of Hematology Medical Oncology, The Indonesian Society of Surgical Oncology, Hematology, Oncology and Stem Cell Transplantation Research Center, Japan Surgical Society (JSS), Japanese Society for Radiation Oncology (JASTRO), Japan Society of Clinical Oncology (JSCO), Japanese Society of Medical Oncology (JSMO), Korean Breast Cancer Society, Korean Cancer Association, Korean Society for Radiation Oncology, Korean Society of Coloproctology, Korean Society of Medical Oncology, Korean Society of Surgical Oncology, The Korean Gastric Cancer Association, Nepal Oncology Society, Radiation Oncology Society of Pakistan (ROS-RS), Society of Medical Oncology Pakistan (SMOP), Philippine Society of Medical Oncology, Molecular Oncology Society of the Philippines, Philippine Cancer Society, Singapore Society of Oncology, Taiwan Oncology Society (TOS), The Thai Society of Clinical Oncology (TSCO), Vietnamese Cancer Society

ARTICLE 4

Members of the AOS shall pay some amount of life-long membership fee, Registration fee of AOS member for annual AOS international symposium will be discounted than that of non-member.

ARTICLE 5

Councilors are the official representatives of each participating country and there may be no more than five councilors from each country. Each councilor will participate as a member of Board of Directors or a member of committees.
Councilors will be nominated by each country in every two years.
Honorary President: Past experience with AOS President
Honorary member: Past experience with AOS Congress President
Meritorious member: Past experience with ACOS council member or APFOCC executive member of the age over 65 years old

ARTICLE 6

Councilors Meetings of the Society shall be held every year for a business meeting and/or a scientific meeting. Meetings of the Board of Directors shall be held when deemed appropriate by the President. The Society shall hold its annual councilors meeting to coincide with the society annual international conference. Time and place will be designated by the host country in coordination with the Board of Directors. The succeeding three international meetings will be decided in advance. The Board of Directors may call special meetings such as clinical guideline meeting, educational meeting for cancer specialist from Asian regions.

ARTICLE 7

The Board of Directors will be gathered at least once a year and have to discuss about AOS future perspective and/or activity, etc.
The members of Board of Directors are the official representative councilor from each participating country.
Meeting of the Board of Directors may be held by letter (formal meeting by letter or e-mail) or by attendance at a meeting. The Meeting of the Board of Directors shall make decisions by sincere agreement or by approval of more than half of the members of the directors.
After discussing with councilors, the below committees will be formed by their agreements such as Meeting of the Scientific Committee, Meeting of the Clinical Research Committee, Meeting of the Clinical Guideline Committee. Meeting of the Educational Committee.

ARTICLE 8

a) AOS President:
    Elected by every two years at the annual councilors meeting, and re-election to a second term will be not acceptable.

b) Congress President of the International Conference (IC) and Vice Congress President (President Elect)
    At every annual councilors meeting, both Congress President (for the next AOS-IC) and Vice Congress President (for the congress after the next AOS-IC) shall be nominated.

c) Secretary General: (more than three councilors).
    The one from the AOS president country and the others are from other countries. Elected by the AOS President by every two years and approved at the annual councilors
    meeting and re-election to a second term will be acceptable.

d) Treasurer: (one councilor)
    Nominated by the AOS President by every two years and approved at the annual councilors meeting.

e) Auditor: (two councilors)
    Nominated by the AOS President by every two
    years and approved at the annual councilors meeting.

f) AOS head Office:
    -The AOS Head office: at AOS President country
    -Branch office: at individual participant countries

ARTICLE 9

The advisory board consists of the former APFOCC Executive members and the former ACOS Board members.

ARTICLE 10

The Board of Directors shall maintain communication with members of the Society through a published newsletters, journal or other methods deemed appropriate by the said Committee. Official Journal of AOS shall be considered as a near future project.

ARTICLE 11

The Board of Directors shall maintain communication with members of the Society through a published newsletters, journal or other methods deemed appropriate by the said Committee. Official Journal of AOS shall be considered as a near future project.

ARTICLE 12

Amendments to the constitution shall be acceptable only for the betterment of the Society. Amendments shall be reviewed by the Board of Directors and shall be approved by more than half of the councilor members of the Society present at the annual councilors meeting of the Society. These amendments must be submitted to the Society at least 4 months before the annual councilors meeting.